BiotechTube

Ceftobiprole medocaril + Daptomycin

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Staphylococcus Aureus Bacteremia

Conditions

Staphylococcus Aureus Bacteremia

Trial Timeline

Aug 26, 2018 → Mar 11, 2022

NCT ID
NCT03138733

About Ceftobiprole medocaril + Daptomycin

Ceftobiprole medocaril + Daptomycin is a phase 3 stage product being developed by Basilea Pharmaceutica for Staphylococcus Aureus Bacteremia. The current trial status is completed. This product is registered under clinical trial identifier NCT03138733. Target conditions include Staphylococcus Aureus Bacteremia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03138733Phase 3Completed

Competing Products

12 competing products in Staphylococcus Aureus Bacteremia

See all competitors
ProductCompanyStageHype Score
Dalbavancin + Vancomycin + Oxacillin + Flucloxacillin + Cefadroxil + ClindamycinAbbViePhase 3
77
AZD7760AstraZenecaPhase 1/2
41
V710 + PlaceboMerckPhase 2/3
65
DaptomycinMerckPhase 2
52
Comparator: Placebo (PBO) + V710 Comparator: Placebo (PBO) + V710 Comparator: Placebo (PBO) + V710 Comparator: Placebo (PBO) + V710 Comparator: Placebo (PBO) + V710 Comparator: Placebo (PBO)MerckPhase 2
52
Imipenem/cilastatinPfizerApproved
84
linezolid (Zyvox) + vancomycinPfizerApproved
84
Linezolid + VancomycinPfizerPre-clinical
22
Aurexis®Bristol Myers SquibbPhase 2
51
Aurexis® (tefibazumab)Bristol Myers SquibbPhase 2
51
blood samples + nasal swabsSanofiPre-clinical
22
514G3 (2 mg/kg) plus standard IV antibiotic treatment + 514G3 (10 mg/kg) plus standard IV antibiotic treatment + 514G3 (40 mg/kg) plus standard IV antibiotic treatment + 514G3 (40 mg/kg) plus standard IV antibiotic treatment: Phase IIXBiotechPhase 1/2
33

Other Products from Basilea Pharmaceutica

alitretinoinPhase 3
72
ceftobiprole medocaril + vancomycin+aztreonamPhase 3
72
alitretinoinPhase 3
72
Fosmanogepix + Fosmanogepix + Caspofungin + Fluconazole + Placebo + Placebo + Placebo + PlaceboPhase 3
72
ceftobiprole medocaril + Vancomycin plus CeftazidimePhase 3
72